ME
Therapeutic Areas
Diamyd Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Retogatein (rhGAD65/alum) | Stage 3 Type 1 Diabetes (recent-onset) | Phase 3 |
Leadership Team at Diamyd Medical
AE
Anders Essen-Möller
Chairman of the Board
EN
Erik Nerpin
Vice Chairman of the Board
TB
Torbjörn Bäckström
Board Member
MA
Mark Atkinson
Board Member
KH
Karin Hehenberger
Board Member
KR
Karin Rosén
Board Member
UH
Ulf Hannelius
Chief Executive Officer
ÅL
Åke Lernmark
Scientific Advisory Board Member
EK
Emily K. Sims
Scientific Advisory Board Member
AL
Alice Long
Scientific Advisory Board Member